|
NUP35 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.212100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.654430E-02 |
| Normal-vs-Stage2 |
2.501800E-01 |
| Normal-vs-Stage3 |
5.108400E-01 |
| Normal-vs-Stage4 |
5.570200E-01 |
| Stage1-vs-Stage2 |
9.576400E-01 |
| Stage1-vs-Stage3 |
3.088400E-01 |
| Stage1-vs-Stage4 |
2.115600E-01 |
| Stage2-vs-Stage3 |
5.483200E-01 |
| Stage2-vs-Stage4 |
4.709200E-01 |
| Stage3-vs-Stage4 |
9.042800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.458000E-02 |
| Normal-vs-AfricanAmerican |
6.450600E-01 |
| Normal-vs-Asian |
4.895200E-01 |
| Caucasian-vs-AfricanAmerican |
1.086600E-01 |
| Caucasian-vs-Asian |
9.330800E-01 |
| AfricanAmerican-vs-Asian |
5.143600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.539600E-01 |
| Normal-vs-Female |
4.044000E-03 |
| Male-vs-Female |
1.996250E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.922000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.106820E-01 |
| Normal-vs-Age(61-80Yrs) |
5.571500E-02 |
| Normal-vs-Age(81-100Yrs) |
3.993000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.421970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.579800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.005000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.378800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.517800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.652600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.933640E-02 |
| Normal-vs-Grade 2 |
4.181000E-04 |
| Normal-vs-Grade 3 |
4.482800E-01 |
| Normal-vs-Grade 4 |
8.110100E-02 |
| Grade 1-vs-Grade 2 |
8.695600E-01 |
| Grade 1-vs-Grade 3 |
1.679170E-01 |
| Grade 1-vs-Grade 4 |
1.794230E-02 |
| Grade 2-vs-Grade 3 |
2.758700E-03 |
| Grade 2-vs-Grade 4 |
1.71992999999926E-05 |
| Grade 3-vs-Grade 4 |
1.641930E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.17809999533591E-08 |
| Normal-vs-ccB subtype |
5.001600E-02 |
| ccA subtype-vs-ccB subtype |
1.71274106008923E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.766200E-02 |
| Normal-vs-N1 |
6.302400E-01 |
| N0-vs-N1 |
3.266000E-01 |
|
|
